Search research articles
Contact Us
Filters
Showing results (571-580 of 706) with videos related to
Page
of 71
Sort By:
JAMA Cardiology
|
May 1, 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
Brian A Bergmark, Jacob A Udell, David A Morrow, et al.
Diabetes, Obesity & Metabolism
|
January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial
Simon R Heller, Richard M Bergenstal, William B White, et al.
European Heart Journal
|
June 3, 2017
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial
Emmanuelle Vidal-Petiot, Amanda Stebbins, Karen Chiswell, et al.
American Heart Journal
|
June 1, 2002
Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program
Christopher P Cannon, Mary H Hand, Raymond Bahr, et al.
The New England Journal of Medicine
|
September 23, 2020
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, et al.
Clinical Cardiology
|
May 27, 2021
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
David S Eccleston, Joseph M Kim, Jurien M Ten Berg, et al.
JAMA Cardiology
|
June 20, 2019
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials
Renato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
American Heart Journal
|
September 29, 2009
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib
Christopher P Cannon, Hayes M Dansky, Michael Davidson, et al.
Journal of the American College of Cardiology
|
November 16, 2017
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry
Avinainder Singh, Bradley L Collins, Ankur Gupta, et al.
JACC. Cardiovascular Interventions
|
December 7, 2019
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis
Jurrien M Ten Berg, Anne de Veer, Jonas Oldgren, et al.
Page
of 71
Search research articles
Search
Showing results (571-580 of 706) with videos related to
Sort By:
Page
of 71
JAMA Cardiology
|
May 1, 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
Brian A Bergmark, Jacob A Udell, David A Morrow, et al.
Diabetes, Obesity & Metabolism
|
January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial
Simon R Heller, Richard M Bergenstal, William B White, et al.
European Heart Journal
|
June 3, 2017
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial
Emmanuelle Vidal-Petiot, Amanda Stebbins, Karen Chiswell, et al.
American Heart Journal
|
June 1, 2002
Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program
Christopher P Cannon, Mary H Hand, Raymond Bahr, et al.
The New England Journal of Medicine
|
September 23, 2020
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
Christopher P Cannon, Richard Pratley, Samuel Dagogo-Jack, et al.
Clinical Cardiology
|
May 27, 2021
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
David S Eccleston, Joseph M Kim, Jurien M Ten Berg, et al.
JAMA Cardiology
|
June 20, 2019
Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials
Renato D Lopes, Hwanhee Hong, Ralf E Harskamp, et al.
American Heart Journal
|
September 29, 2009
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib
Christopher P Cannon, Hayes M Dansky, Michael Davidson, et al.
Journal of the American College of Cardiology
|
November 16, 2017
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry
Avinainder Singh, Bradley L Collins, Ankur Gupta, et al.
JACC. Cardiovascular Interventions
|
December 7, 2019
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis
Jurrien M Ten Berg, Anne de Veer, Jonas Oldgren, et al.
Page
of 71